As a healthcare company, Novo Nordisk Inc. is committed to delivering value through a patient-centered business approach. This means we must be uncompromising when it comes to quality and ethics.
Our US Code of Business Conduct states the ethical and compliance principles that guide our company, our employees and the interactions we have with our stakeholders. Our Code ensures that our values are reflected in daily work and that we enhance the transparency of our activities for all stakeholder groups. It informs and directs business practices as outlined by our Corporate Compliance Program and corporate philosophies and reflects the Novo Nordisk Way—our global commitment to patients, our employees and our shareholders.
Novo Nordisk is committed to compliance with all federal healthcare program and Food and Drug Administration (FDA) requirements in all of our activities, including the way we market, sell, promote, research, develop, provide information about, and advertise our products. We are committed to compliance with the provisions of the Patient Protection and Affordable Care Act to report our financial relationships with healthcare professionals and institutions. We are striving to enhance the transparency of our interactions with healthcare professionals and institutions related to our payments, prescription drug samples, clinical trial support, and grants and charitable gifts that we provide to various organizations.